Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy

Texture analysis of T2-weighted cardiovascular magnetic resonance imaging to discriminate between cardiac amyloidosis and hypertrophic cardiomyopathy

Abstract Background To elucidate the value of texture analysis (TA) in detecting and differentiating myocardial tissue alterations on T2-weighted CMR (cardiovascular magnetic resonance imaging) in patients with cardiac amyloidosis (CA) and hypertrophic cardiomyopathy (HCM). Methods In this retrospec...

Descripció completa

Dades bibliogràfiques
Autors principals:	Shan Huang, Ke Shi, Yi Zhang, Wei-Feng Yan, Ying-Kun Guo, Yuan Li, Zhi-Gang Yang
Format:	Article
Idioma:	English
Publicat:	BMC 2022-05-01
Col·lecció:	BMC Cardiovascular Disorders
Matèries:	Texture analysis Cardiac amyloidosis Hypertrophic cardiomyopathy Left ventricular hypertrophy
Accés en línia:	https://doi.org/10.1186/s12872-022-02671-0

Ítems similars

Hypertrophic Cardiomyopathy
per: Polakit Teekakirikul, MD, et al.
Publicat: (2021-09-01)

Electro‐ and echocardiographic features of left ventricle hypertrophy in patients with hypertrophic cardiomyopathy
per: Karolina Bula, et al.
Publicat: (2022-09-01)

A rare case of apical hypertrophic cardiomyopathy (AHCM)
per: Seyed Abbas Mirabbasi, et al.
Publicat: (2017-04-01)

Inter-ventricular Septum Ablation for the Treatment of Hypertrophic Obstructive Cardiomyopathy
per: Yuejin Wu, MS, Shaobo Duan, MD, Luwen Liu, MS, Shuaiyang Wang, MS, Shuang Xu, MS, Liuwei Hao, BS, Lianzhong Zhang, MD
Publicat: (2020-12-01)

Cardiac Amyloidosis Masquerading as Hypertrophic Obstructive Cardiomyopathy: Co-existence or Coincidence?
per: Madhu Shukla, et al.
Publicat: (2024-07-01)

Hypertrophic Cardiomyopathy and Chronic Kidney Disease: An Updated Review
per: Sheefah Dhuny, et al.
Publicat: (2024-01-01)

Left Ventricular Noncompaction Masquerading as Hypertrophic Nonobstructive Cardiomyopathy
per: Praveen Rermal Veedu, et al.
Publicat: (2023-01-01)

Left Atrial Strain Imaging by Speckle Tracking Echocardiography: The Supportive Diagnostic Value in Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
per: Ines Paola Monte, et al.
Publicat: (2023-06-01)

Clinical manifestation and outcomes of children with hypertrophic cardiomyopathy in Kosovo
per: Ramush A Bejiqi, et al.
Publicat: (2020-04-01)

Unraveling an Unusual Phenocopy of Hypertrophic Cardiomyopathy: MELAS Syndrome
per: Anna B. Reid, et al.
Publicat: (2021-02-01)

GLA Gene Mutation in Hypertrophic Cardiomyopathy with a New Variant Description: Is it Fabry's Disease?
per: Ândrea Virgínia Chaves-Markman, et al.

Echocardiographic markers of left ventricular hypertrophy and concentric remodeling – limitations in diagnostics of cardiac amyloidosis, Fabry disease and hypertrophic cardiomyopathy
per: Judyta Znamirowska, et al.
Publicat: (2024-09-01)

Algorithm for Investigation of Fabry Disease in Cardiomyopathies
per: Sandra Marques e Silva, et al.
Publicat: (2024-10-01)

Deep Learning Supplants Visual Analysis by Experienced Operators for the Diagnosis of Cardiac Amyloidosis by Cine-CMR
per: Philippe Germain, et al.
Publicat: (2021-12-01)

Role of Septal Myectomy in Pediatric Hypertrophic Cardiomyopathy
per: Sameh M. Said
Publicat: (2024-09-01)

Speckle tracking as an adjunctive echocardiographic technique for differentiating cardiac amyloidosis from hypertrophic cardiomyopathy: A case study
per: Sandya Nandakumar, et al.
Publicat: (2017-01-01)

Derivation and Validation of a Screening Model for Hypertrophic Cardiomyopathy Based on Electrocardiogram Features
per: Lanyan Guo, et al.
Publicat: (2022-05-01)

Hypertrophic cardiomyopathy is characterized by alterations of the mitochondrial calcium uniporter complex proteins: insights from patients with aortic valve stenosis versus hypertrophic obstructive cardiomyopathy
per: Vera Paar, et al.
Publicat: (2023-11-01)

Differential Diagnosis of Cardiac Amyloidosis and Hypertrophic Cardiomyopathy
per: M. S. Bychkova, et al.
Publicat: (2023-10-01)

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
per: Lazar Velicki, et al.
Publicat: (2020-12-01)

ASSOCIATIONS BETWEEN CLINICAL COURSE, LEFT VENTRICULAR HYPERTROPHY SEVERITY AND ACE GENE I/D POLYMORPHISM IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY AND HYPERTENSIVE HEART
per: M. D. Smirnova, et al.
Publicat: (2009-04-01)

Differentiating between cardiac amyloidosis and hypertrophic cardiomyopathy on non-contrast cine-magnetic resonance images using machine learning-based radiomics
per: Shu Jiang, et al.
Publicat: (2022-10-01)

Echocardiography in Hypertrophic Cardiomyopathy
per: Rahul Mehrotra
Publicat: (2024-08-01)

Diagnosis and Clinical Implication of Left Ventricular Aneurysm in Hypertrophic Cardiomyopathy
per: Errico Federico Perillo, et al.
Publicat: (2023-05-01)

Left ventricular remodeling in hypertrophic cardiomyopathy patients with atrial fibrillation
per: Hongwei Tian, et al.
Publicat: (2018-11-01)

Cardiovascular magnetic resonance in hypertrophic cardiomyopathy and infiltrative cardiomyopathy
per: Rebecca Schofield, et al.
Publicat: (2016-11-01)

Gender Related Differences in the Clinical Presentation of Hypertrophic Cardiomyopathy—An Analysis from the SILICOFCM Database
per: Andrej Preveden, et al.
Publicat: (2022-02-01)

Diagnosis of a rare combination of hypertrophic and left ventricular noncompaction cardiomyopathy using cardiac magnetic resonance imaging
per: Sinem Özyılmaz, et al.
Publicat: (2016-07-01)

Limitations of electrocardiographic criteria of left ventricular hypertrophy in differentiation between hypertrophic cardiomyopathy, cardiac amyloidosis and Fabry disease
per: Mateusz Tometczak, et al.
Publicat: (2024-07-01)

The differential diagnostic value of left ventricular segmental myocardial strain in cardiac amyloidosis and non-obstructive hypertrophic cardiomyopathy
per: Yang LIU, et al.
Publicat: (2024-12-01)

Apical hypertrophic cardiomyopathy: contemporary view on the prevalence, clinical profile, diagnostic and treatmen (review of literature)
per: A. A. Streltsova, et al.
Publicat: (2021-10-01)

Diagnosis and Treatment of Obstructive Hypertrophic Cardiomyopathy
per: Gaetano Todde, et al.
Publicat: (2023-05-01)

Syndrome of Reversible Cardiogenic Shock and Left Ventricular Ballooning in Obstructive Hypertrophic Cardiomyopathy
per: Mark V. Sherrid, et al.
Publicat: (2021-10-01)

Arritmias ventriculares e hipertrofia ventricular esquerda na cardiomiopatia hipertrófica Ventricular arrhythmias and left ventricular hypertrophy in hypertrophic cardiomyopathy
per: Beatriz Piva e Mattos, et al.
Publicat: (2013-05-01)

Il coinvolgimento cardiaco nella malattia di Fabry
per: Maurizio Pieroni
Publicat: (2017-09-01)

Retrospective analysis of cardiovascular involvement in patients with systemic amyloidosis
per: E. V. Reznik, et al.
Publicat: (2021-02-01)

CMR left ventricular strains beyond global longitudinal strain in differentiating light-chain cardiac amyloidosis from hypertrophic cardiomyopathy
per: Fangqing Wang, et al.
Publicat: (2023-05-01)

Impact of cibenzoline treatment on left ventricular remodelling and prognosis in hypertrophic obstructive cardiomyopathy
per: Mareomi Hamada, et al.
Publicat: (2021-12-01)

Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman
per: O. V. Blagova, et al.
Publicat: (2020-05-01)

Comparison of cardiac amyloidosis and hypertrophic cardiomyopathy: retrospective analysis of cardiac and kidney lesion
per: E. V. Reznik, et al.
Publicat: (2023-11-01)